ASHOK BEHERA

@dituniversity.edu.in

Asst Prof/Faculty of Pharmacy
DIT University

ASHOK BEHERA


                     Download Compact PDF  
https://researchid.co/ashokiicb2015

EDUCATION

Examination /Degree Board/Council/
University/Other
Examining Body Duration of the Course & Year of Completion Division/ Class with % of Marks/
Ph.D.
(Pharmacy) Jadavpur
University (CSIR-IICB) registration:
13/06/2011 awarded on 27/06/2014 submitted 18/06/2013
NA
M.S
(Pharm) National Institute of Pharmaceutical
Education and
Research
(NIPER)-Kolkata 2yr, June 2009 CGPA-
9.46/10
(89.60%)

RESEARCH INTERESTS

chemistry to chemical biology. Specifically, my research focuses on the following areas:
 Peptidomimetics and Peptide conjugates as therapeutics and drug delivery
 Receptor specific targeted drug delivery
 Computer aided drug design
 Organic synthesis and purification: Solid phase peptide synth
27

Scopus Publications

517

Scholar Citations

10

Scholar h-index

11

Scholar i10-index

Scopus Publications

  • Integrative strategies and future perspectives to mitigate chemical toxicity in human and aquatic systems
    Aman Chaudhary, Gunjan Tyagi, Kumari Rashmi Singh, Ashok Behera
    Discover Environment, 2026
    Human exposure to hazardous chemicals occurs through multiple pathways, including inhalation, ingestion, dermal contact, and consumption of contaminated water, leading to adverse outcomes such as systemic toxicity, and chronic diseases. The release of these contaminants into aquatic ecosystems primarily from industrial discharge, agricultural runoff, and urban effluents has significant ecological ramifications. This review aims to synthesize recent findings on the sources, pathways, toxicological impacts, and mitigation strategies related to chemical pollutants in aquatic environments and human health. A structured literature review was conducted using databases including Google Scholar, PubMed, Scopus, ScienceDirect, and ResearchGate, with search terms such as “chemical toxicity,” “heavy metal contamination,” “microplastic bioaccumulation,” “aquatic toxicity and health,” “bioremediation of pollutants,” and “green chemistry.” Findings reveal that prolonged exposure to toxic substances is linked to tumors, immune suppression, reproductive dysfunction, developmental delays, and congenital anomalies in humans. Aquatic organisms are similarly impacted by pollutants from pharmaceuticals, pesticides, oil derivatives, and antifouling agents, with documented cases of endocrine disruption and teratogenic effects. Environmental chemical toxicity management still faces major obstacles despite advancements in risk assessment, chemical monitoring, and mitigation techniques. Analytical limitations continue to limit the detection of new pollutants at trace levels, and complicated exposure pathways and mixing effects make estimates of ecological and human risk more difficult. Advanced cleanup methods may be expensive or challenging to apply at scale, and regulatory regimes are sometimes varied across areas. Furthermore, less is known about the long-term, chronic, and synergistic consequences of low-dose exposures, underscoring the necessity of integrated, interdisciplinary methods. This study notably tackles the research gap by integrating human health outcomes with aquatic toxicological information and emphasizing new sustainable mitigation solutions from a unified chemical management viewpoint.
  • Design and evaluation of casein nanoparticles for co-delivery of curcumin and fluorouracil acetic acid in cancer therapy
    Aman Chaudhary, Ashok Behera, Jagannath Sahoo
    Medical Oncology, 2025
  • Isolation, characterization and therapeutic potential of a novel furanoid diterpene lactone from Hedychium spicatum rhizomes: Insights into antioxidant, anxiolytic, and circadian rhythm modulating properties
    Alok Pratap Singh, Rajeev Kumar Sharma, Ashok Behera, Jay Ballabh Kandpal, Havagiray Chitme, Pankaj Pant
    Phytomedicine Plus, 2024
    Hedychium spicatum rhizomes is widely used in ayurvedic medicine and traditional medicine systems around the Himalayas. Standardization of Hedychium spicatum rhizome SCFE extract by Identification, Isolation, characterization, and screening of pharmacological activity of phytoconstituents. Supercritical fluid extraction, column chromatography, spectroscopic analysis, in-silico, and in-vivo study of compound 1 (3-((E) -2-((1S,8aR)-3,5,5,8a-tetramethyl-4-oxo-1,4,4a,5,6,7,8,8a-octahydro-naphthalen-1-yl) vinyl) furan-2(5H)-one). A supercritical fluid extract was prepared and further purified to obtain a novel Furanoid diterpene lactone compound 1 (3-((E) -2-((1S,8aR)-3,5,5,8a-tetramethyl-4-oxo-1,4,4a,5,6,7,8,8a-octahydro-naphthalen-1-yl) vinyl) furan-2(5H)-one). It was characterised using IR, LC-ESI/MS, 1H, 13C NMR, 2D NMR-COSY, NOESY, HMBC, and HSQC and thin-layer chromatography. Compound was tested for anxiolytic activity using various animal behavioural model included elevated maze plus test, light and dark box test, social interaction, Actophotometer test, rotarod test. The compound gives a false Dragendorff's test in favour of the presence of lactone. HPLC profiling was done using DAD using 30% v/v of o-phosphoric acid (0.1% v/v) in water and 70% v/v of acetonitrile (ACN) in the mobile phase. Compound 1 having significant anxiolytic effect tested in animal behavioural model ****p<0.0001 diazepam as standard. Free radical scavenging activity suggested that compound 1 has good potential as an antioxidant, having IC50 values of 75.62 µg and 96.556 µg using DPPH and ABTS inhibition assays. ADMET prediction suggested that compound 1 follows Lipinski's rules of five, absorbed through the intestine, and penetrates the blood-brain barrier and CNS. In-silico studies, suggested that compound 1 has an affinity to bind with GABA, melatonin 1, and glutamate receptor 5 and In-vivo study suggest compound 1 will be a good candidate as anxiolytic agent. It can be used as a promising natural remedy for oxidative stress, mental health issues, and sleep-related disorders, warranting further exploration and clinical investigation.
  • Characteristics of the COPD Patients for the Implementation of the Smartphone Application for the COPD: An Implementation Study
    Ashwani Verma, Ashok Behera, Ravishankar N, Monirul Islam, Vaishali K, Mukesh Kumar Sinha, Aditya Jayaraj, Ashok Kumar Singh, Pushpendra Kumar Verma
    National Journal of Community Medicine, 2024
    Background: This study provides us an opportunity to discuss about the development of a smartphone enabled Home based Self-management application for Chronic Obstructive Pulmonary Disease. Objective: To summarize the baseline characteristics of the Chronic Obstructive Pulmonary Disease patients recruited in present study. Methods: A single centered prospective non-randomized study has been conducted to implement the self-management application among 166 patients. Patients were matched based on gender and Global Initiative for Obstructive Lung Disease criteria. Smartphone application was provided to the intervention group and instructions were given to them. Results: The mean age of participants was 58.02 years in which more than half were male, more than 80% were married, almost one-third were educated up to class 10th, more than 65% have disease duration between 3 to 8 years, equally distributed for Grade 2 and 3 and two third were ex-smokers. The St. George's Respiratory Questionnaire score was 40.20 and 39.74, Clinical COPD Questionnaire score was 3.89 and 3.86, COPD Assessment Test score was 23.65 and 22.74 in intervention and control group respectively. There is no statistically significant difference between the group. Conclusion: The findings of present study provide a vital context for the follow-up results of the evaluation study.
  • A systematic study on herbal cream for various clinical and therapeutic application: current status and future prospects
    Arushi, Ashok Behera, Neeraj K. Sethiya, Satish Shilpi
    Journal of Herbal Medicine, 2024
  • Pharmacological Potential of Sulindac and Its Active Metabolite: A Comprehensive Review
    Shraddha Manish Gupta, Ashok Behera, Siddharth Singh
    Current Drug Therapy, 2024
    : In this review, we describe and discuss the pharmaceutical aspects, pharmacokinetic profile, and preclinical and clinical studies of sulindac and its active metabolite and emphasise their potential activity not only in anti-inflammation strategies but also as chemoprevention drug candidates. Though they are widely validated through in vitro and in vivo models, to date, no efforts have been made to compile in a single review on their pharmacologically potential, pharmacokinetics and toxicity profiles. Key databases such as PubMed, Science Direct, Scopus, and Google Scholar, among others, were probed for a systematic search using keywords to retrieve relevant publications. An exhaustive electronic survey of the related literature on the pharmacologically potential activity and the pharmacokinetic and toxicity profiles of sulindac resulted in around 200 articles (1975 and 2023) being included. The studies conducted on sulindac sulphide and sulindac sulfone metabolites reported a varied range of biological effects deployed in this review. The review concluded that there is scope for repurposing sulindac using computer-aided drug design and biological study to find out possible new targets for strengthening the potency and selectivity of the metabolites.
  • In-vitro, in-vivo and in-silico anti-inflammatory evaluation of hedychenone and its semisynthetic derivative
    Alok Pratap Singh, Rajeev Kumar Sharma, Ashok Behera, J.B. Kandpal, Havagiray Chitme
    Journal of Biologically Active Products from Nature, 2024
    Hedychium spicatum is a perennial shrub that is commonly found in the Himalayan region. Thin layer chromatography fingerprint screening of various Hedychium species revealed that only the species Hedychium spicatum possesses hedychenone. Purification and isolation of hedychenone was carried out from methanolic extract of Hedychium spicatum rhizomes powder using column chromatography. After crystallization of enriched fraction, 2.19% of hedychenone crystalline powder was yielded. The physiochemical, pharmacokinetic, and pharmacodynamic evaluation of the active pharmaceutical components was conducted using artificial learning and machine learning (AL/ML) approaches. The results indicate that both medications adhere to Lipinski’s rule of five. The docking study indicated that compound 2 (MBE-10.4 kcal/mol) exhibited a more sub-stantial interaction with the cannabinoid receptor 2 compared to hedychenone (MBE -9.85 kcal/mol). A study was done to assess the physical and chemical stability of hedychenone under biological pH conditions. Furthermore, the administration of both medication concentrations, 100 mg/kg and 200 mg/ kg, effectively inhibits the development of acute paw edema caused by ovalbumin. A preliminary investigation of hedychenone and its synthetic derivative indicated that these compounds have the potential to be utilized as active medicinal ingredients in herbal pharmaceutical preparations.
  • Artificial intelligence-based protein structure prediction and systems biology-guided smart drug screening
    Anshuman Chandra, Nainee Goyal, Ashok Behera, Jhuma Samanta, Tripti Sharma
    Biochemical and Molecular Pharmacology in Drug Discovery, 2024
  • Clinical Trial on and Regulatory Considerations for Herbal Medicines for Lifestyle Diseases
    Samir Bhargava, Amal Kumar Dhara, Manmohan Singhal, Neeraj Kr. Sethiya, Bhavna, Satish Shilpi, Vijay Singh Rana, Amit Kr. Dubey, Ashok Behera, Anuj Nautiyal
    Role of Herbal Medicines Management of Lifestyle Diseases, 2024
  • Nanotherapeutics for diabetic nephropathy using metal nanocomposites
    Jhuma Samanta, Ashok Behera, Aman Chaudhary
    Metal Nanocomposites in Nanotherapeutics for Oxidative Stress Induced Metabolic Disorders, 2023
    Diabetes affected 415 million people globally in 2015, and experts predict that number will rise to 642 million by 2040, as per the International Diabetes Federation’s 2015 report. Cardiac complications, retinopathy, nephropathy, and neuropathy are associated with diabetes. The most common cause of mortality is diabetes nephropathy (DN), which affects two million people per year, as estimated in 2019. DN increases mortality by increasing cardiovascular risk and kidney diseases. Angiotensin-converting enzyme inhibitors (ACEIs), hypoglycemic agents, angiotensin receptor blockers (ARBs), and acetylsalicylic acid are some other therapeutic agents used to control DN. Multiple signaling pathways and multiple targets are associated with DN, so a specifically targeted delivery gadget is almost essential for safe and efficacious medication. Delivery of potent medicaments to targeted tissues is one of the most challenging issues. Selective delivery of the drug to the diseased cell can treat the patient without affecting healthy tissues, which reduces side effects and dosing issues. In the current era, the most revolutionary and promising drug delivery system is nanotherapeutics. Nanocomposites, a conglomerated form of inorganic nanoparticles and organic/synthetic polymer matrix, are reliable tools to deliver these therapeutic agents to their respective targets. This chapter explores raw materials, preparation methods, characterization, and metal-nanocomposites attributes to DN. Here we discuss the prospects in connection with health, industries, and economics, as well as technological limitations and applications of metal nanocomposites. The chapter concludes with the social significance of the same.
  • Concentration- and Solvent-Induced Chiral Tuning by Manipulating Non-Proteinogenic Amino Acids in Glycoconjugate Supra-Scaffolds: Interaction with Protein, and Streptomycin Delivery
    Angshuman Ghosh, Jishu Mandal, Soumen Kumar Dubey, Somrita Padma, Narendra Nath Ghosh, Ashok Behera, Sk Abdul Hafiz, Pradip Ruidas, Ramkrishna Midya, Dipanwita Roy, Dona Das, Surajit Das, Somendra Singh, Sankar Bhattacharyya, Suprabhat Mukherjee, Subham Bhattacharjee
    Chemistry A European Journal, 2023
  • Mapping of digital health interventions for the self-management of COPD: A systematic review
    Ashwani Verma, Ashok Behera, Rohitashwa Kumar, Nachiket Gudi, Ashish Joshi, KM Monirul Islam
    Clinical Epidemiology and Global Health, 2023
  • Development of substituted benzylidene derivatives as novel dual cholinesterase inhibitors for Alzheimer's treatment
    Shraddha Manish Gupta, Ashok Behera, Neetesh K. Jain, Avanish Tripathi, Dinesh Rishipathak, Siddharth Singh, Nafees Ahemad, Meryem Erol, Devendra Kumar
    Rsc Advances, 2023
  • Development, Implementation, And Evaluation of An Informatics Platform for Home Based Self-Management of Chronic Obstructive Pulmonary Disease: A Study Protocol
    Ashwani Verma, Ashok Behera, KM Monirul Islam, Ashish Joshi
    National Journal of Community Medicine, 2023
  • Smart Advancements for Targeting Solid Tumors via Protein and Peptide Drug Delivery (PPD)
    Shraddha Manish Gupta, Siddharth Singh, Priyanka Sanwal, Samir Bhargava, Ashok Behera, Shuchi Upadhyay, Md. Habban Akhter, Manish Gupta
    Current Drug Delivery, 2023
  • Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review
    Taha Alqahtani, Sharada L. Deore, Anjali A. Kide, Bhavana A. Shende, Ritika Sharma, Rita Dadarao Chakole, Lalita S. Nemade, Nikita Kishor Kale, Sudarshana Borah, Savita Shrikant Deokar, Ashok Behera, Divya Dhawal Bhandari, Nikita Gaikwad, Abul Kalam Azad, Arabinda Ghosh
    Mitochondrion, 2023
  • A Comprehensive Review on Pharmacologically Active Phyto-Constituents from Hedychium species
    Alok Pratap Singh, Havagiray Chitme, Rajeev Kumar Sharma, JB Kandpal, Ashok Behera, Basel A. Abdel-Wahab, Mohammed Abdelmalek Orabi, Masood Medleri Khateeb, Mohammed Habeeb, Marwa B. Bakir
    Molecules, 2023
  • Computational Investigation of the Interaction of Novel Indene Methylene Analogues with Acetylcholinesterase from Both Dynamic and Thermody-namic Perspectives
    Shraddha M. Gupta, Neetesh K. Jain, Rohitash Yadav, Meryem Erol, Ismail Celik, Manish Gupta, Ashok Behera
    Letters in Drug Design and Discovery, 2023
  • Indene-Derived Hydrazides Targeting Acetylcholinesterase Enzyme in Alzheimer’s: Design, Synthesis, and Biological Evaluation
    Shraddha Manish Gupta, Ashok Behera, Neetesh K. Jain, Devendra Kumar, Avanish Tripathi, Shailesh Mani Tripathi, Somdutt Mujwar, Jeevan Patra, Arvind Negi
    Pharmaceutics, 2023
  • Copper-Catalyzed Electrophilic Ortho C(sp2)-H Amination of Aryl Amines: Dramatic Reactivity of Bicyclic System
    Hasina Mamataj Begam, Rajarshee Choudhury, Ashok Behera, Ranjan Jana
    Organic Letters, 2019
  • Metabolic stability and biological evaluation of 99mTc-HYNIC-Tyr3-Octreotide as somatostatin receptor positive tumor imaging agent
    Ashok Behera, Kakali De, Sankha Chattopadhayay, Mridula Misra
    Journal of Radioanalytical and Nuclear Chemistry, 2015
  • Synthesis, characterization, biodistribution and scintigraphy of 99mTc-paclitaxel: a potential tracer of paclitaxel
    Indranil Banerjee, Ashok Behera, Kakali De, Sankha Chattopadhyay, Satbir Singh Sachdev, Bharat Sarkar, Santanu Ganguly, Mridula Misra
    Journal of Radioanalytical and Nuclear Chemistry, 2015
  • Radiolabeled novel peptide for imaging somatostatin-receptor expressing tumor: Synthesis and radiobiological evaluation
    Kakali De, Asoke Behera, Indranil Banerjee, Bharat Sarkar, Santanu Ganguly, Mridula Misra
    Journal of Radioanalytical and Nuclear Chemistry, 2014
  • Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of 99mTc-HYNIC-His 3-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors
    Ashok Behera, Indranil Banerjee, Kakali De, Rudra Narayan Munda, Sankha Chattopadhayay, Amalesh Samanta, Bharat Sarkar, Santanu Ganguly, Mridula Misra
    Amino Acids, 2013
  • Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy
    Kakali De, Arijit Bhowmik, Ashok Behera, Indranil Banerjee, Mrinal Kanti Ghosh, Mridula Misra
    Journal of Peptide Science, 2012
  • A modified synthetic approach to optically pure benzoxazepines from amino acid precursors using intramolecular buchwald-hartwig C-O bond-formation reaction
    Partha Chattopadhyay, Debleena Bhattacharya, Ashok Behera, Sandip Hota
    Synthesis, 2011
  • Synthesis, radiolabelling and biodistribution of HYNIC-Tyr3 octreotide: A somatostatin receptor positive tumour imaging agent
    Ashok Behera, Kakali De, Susmita Chandra, Sankha Chattopadhyay, Mridula Misra
    Journal of Radioanalytical and Nuclear Chemistry, 2011

RECENT SCHOLAR PUBLICATIONS

  • Integrative strategies and future perspectives to mitigate chemical toxicity in human and aquatic systems
    A Chaudhary, G Tyagi, KR Singh, A Behera
    Discover Environment 4 (1), 165 , 2026
    2026
  • Changing Coastal Landscapes: The Role of Climate Change in Biodiversity Loss and Desertification
    AK Behera, R Chandra
    Navigating Climate Change: Impacts on Biodiversity and Ecosystem Resilience … , 2025
    2025
    Citations: 1
  • Design and evaluation of casein nanoparticles for co-delivery of curcumin and fluorouracil acetic acid in cancer therapy
    A Chaudhary, A Behera, J Sahoo
    Medical Oncology 42 (8), 335 , 2025
    2025
    Citations: 1
  • A Systematic Review for Conducting a Meta-analysis: Synthesis from Multiple Studies in the Coastal Ecosystem of Odisha
    AK Behera, R Chandra
    Mahanadi River: The Environmental Challenges and Way Forward, 17-39 , 2025
    2025
    Citations: 1
  • Pharmacological Potential of Sulindac and Its Active Metabolite: A Comprehensive Review
    SM Gupta, A Behera, S Singh
    Current Drug Therapy 19 (7), 765-779 , 2024
    2024
    Citations: 3
  • Characteristics of the COPD Patients for the Implementation of the Smartphone Application for the COPD: An Implementation Study
    A Verma, A Behera, M Islam, MK Sinha, A Jayaraj, AK Singh, PK Verma
    National Journal of Community Medicine 15 (08), 685-690 , 2024
    2024
  • Isolation, characterization and therapeutic potential of a novel furanoid diterpene lactone from Hedychium spicatum rhizomes: Insights into antioxidant, anxiolytic, and …
    AP Singh, RK Sharma, A Behera, JB Kandpal, H Chitme, P Pant
    Phytomedicine Plus 4 (3), 100597 , 2024
    2024
    Citations: 1
  • A systematic study on herbal cream for various clinical and therapeutic application: current status and future prospects
    A Behera, NK Sethiya, S Shilpi
    Journal of Herbal Medicine 45, 100880 , 2024
    2024
    Citations: 6
  • In-vitro , in-vivo and in-silico anti-inflammatory evaluation of hedychenone and its semisynthetic derivative
    AP Singh, RK Sharma, A Behera, JB Kandpal, H Chitme
    Journal of Biologically Active Products from Nature 14 (2), 199-229 , 2024
    2024
    Citations: 1
  • Clinical Trial on and Regulatory Considerations for Herbal Medicines for Lifestyle Diseases
    S Bhargava, AK Dhara, M Singhal, NK Sethiya, Bhavna, S Shilpi, ...
    Role of Herbal Medicines: Management of Lifestyle Diseases, 573-595 , 2024
    2024
  • Artificial intelligence-based protein structure prediction and systems biology-guided smart drug screening
    A Chandra, N Goyal, A Behera, J Samanta, T Sharma
    Biochemical and Molecular Pharmacology in Drug Discovery, 323-352 , 2024
    2024
    Citations: 3
  • Nanotherapeutics for diabetic nephropathy using metal nanocomposites
    J Samanta, A Behera, A Chaudhary
    Metal Nanocomposites in Nanotherapeutics for Oxidative Stress-Induced … , 2023
    2023
  • Concentration‐and Solvent‐Induced Chiral Tuning by Manipulating Non‐Proteinogenic Amino Acids in Glycoconjugate Supra‐Scaffolds: Interaction with Protein, and Streptomycin Delivery
    A Ghosh, J Mandal, SK Dubey, S Padma, NN Ghosh, A Behera, SA Hafiz, ...
    Chemistry–A European Journal 29 (70), e202302529 , 2023
    2023
    Citations: 5
  • Computational Investigation of the Interaction of Novel Indene Methylene Analogues with Acetylcholinesterase from Both Dynamic and Thermodynamic Perspectives
    SM Gupta, NK Jain, R Yadav, M Erol, I Celik, M Gupta, A Behera
    Letters in Drug Design & Discovery 20 (12), 1911-1921 , 2023
    2023
  • Mapping of digital health interventions for the self-management of COPD: A systematic review
    A Verma, A Behera, R Kumar, N Gudi, A Joshi, KMM Islam
    Clinical Epidemiology and Global Health 24, 101427 , 2023
    2023
    Citations: 15
  • Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis-an updated review
    T Alqahtani, SL Deore, AA Kide, BA Shende, R Sharma, RD Chakole, ...
    Mitochondrion 71, 83-92 , 2023
    2023
    Citations: 276
  • Development, Implementation, And Evaluation of An Informatics Platform for Home Based Self-Management of Chronic Obstructive Pulmonary Disease: A Study Protocol
    A Verma, A Behera, KMM Islam, A Joshi
    National Journal of Community Medicine 14 (07), 446-451 , 2023
    2023
    Citations: 3
  • A Comprehensive Review on Pharmacologically Active Phyto-Constituents from Hedychium species
    AP Singh, H Chitme, RK Sharma, JB Kandpal, A Behera, ...
    Molecules 28 (7), 3278 , 2023
    2023
    Citations: 17
  • Development of substituted benzylidene derivatives as novel dual cholinesterase inhibitors for Alzheimer's treatment
    SM Gupta, A Behera, NK Jain, A Tripathi, D Rishipathak, S Singh, ...
    RSC advances 13 (38), 26344-26356 , 2023
    2023
    Citations: 10
  • Indene-derived hydrazides targeting acetylcholinesterase enzyme in Alzheimer’s: design, synthesis, and biological evaluation
    SM Gupta, A Behera, NK Jain, D Kumar, A Tripathi, SM Tripathi, S Mujwar, ...
    Pharmaceutics 15 (1), 94 , 2022
    2022
    Citations: 26

MOST CITED SCHOLAR PUBLICATIONS

  • Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis-an updated review
    T Alqahtani, SL Deore, AA Kide, BA Shende, R Sharma, RD Chakole, ...
    Mitochondrion 71, 83-92 , 2023
    2023
    Citations: 276
  • Copper-Catalyzed Electrophilic Ortho C(sp2)–H Amination of Aryl Amines: Dramatic Reactivity of Bicyclic System
    HMBRCABR Jan
    Org. Lett. 21 (12), 4651-4656 , 2019
    2019
    Citations: 43
  • Indene-derived hydrazides targeting acetylcholinesterase enzyme in Alzheimer’s: design, synthesis, and biological evaluation
    SM Gupta, A Behera, NK Jain, D Kumar, A Tripathi, SM Tripathi, S Mujwar, ...
    Pharmaceutics 15 (1), 94 , 2022
    2022
    Citations: 26
  • Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor‐positive tumor scintigraphy
    K De, A Bhowmik, A Behera, I Banerjee, MK Ghosh, M Misra
    Journal of Peptide Science 18 (12), 720-730 , 2012
    2012
    Citations: 25
  • A Comprehensive Review on Pharmacologically Active Phyto-Constituents from Hedychium species
    AP Singh, H Chitme, RK Sharma, JB Kandpal, A Behera, ...
    Molecules 28 (7), 3278 , 2023
    2023
    Citations: 17
  • Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of 99m Tc-HYNIC-His 3 -Octreotate as novel …
    A Behera, I Banerjee, K De, RN Munda, S Chattopadhayay, A Samanta, ...
    Amino Acids 44 (3), 933-946 , 2013
    2013
    Citations: 16
  • Mapping of digital health interventions for the self-management of COPD: A systematic review
    A Verma, A Behera, R Kumar, N Gudi, A Joshi, KMM Islam
    Clinical Epidemiology and Global Health 24, 101427 , 2023
    2023
    Citations: 15
  • Sintered flyash lightweight aggregate-Its properties and performance in structural concrete
    PN Ojha, B Singh, AK Behera
    Indian Concr J 95 (6), 20-30 , 2021
    2021
    Citations: 15
  • Synthesis, radiolabelling and biodistribution of HYNIC-Tyr 3 octreotide: a somatostatin receptor positive tumour imaging agent
    A Behera, K De, S Chandra, S Chattopadhyay, M Misra
    Journal of Radioanalytical and Nuclear Chemistry 290 (1), 123-129 , 2011
    2011
    Citations: 15
  • Development of substituted benzylidene derivatives as novel dual cholinesterase inhibitors for Alzheimer's treatment
    SM Gupta, A Behera, NK Jain, A Tripathi, D Rishipathak, S Singh, ...
    RSC advances 13 (38), 26344-26356 , 2023
    2023
    Citations: 10
  • A Modified Synthetic Approach to Optically Pure Benzoxazepines from Amino Acid Precursors Using Intramolecular Buchwald-Hartwig CO Bond-Formation Reaction
    D Bhattacharya, A Behera, SK Hota, P Chattopadhyay
    Synthesis 2011 (04), 585-592 , 2011
    2011
    Citations: 10
  • Smart Advancements for Targeting Solid Tumors via Protein and Peptide Drug Delivery (PPD)
    SMG Siddharth Singh, Priyanka Sanwal, Samir Bhargava, Ashok Behera, Shuchi ...
    Curr Drug Deliv 35490321 (10.2174/1567201819666220427132734), 10.2174 … , 2022
    2022
    Citations: 9
  • Synthesis, characterization, biodistribution and scintigraphy of 99m Tc-paclitaxel: a potential tracer of paclitaxel
    I Banerjee, A Behera, K De, S Chattopadhyay, SS Sachdev, B Sarkar, ...
    Journal of Radioanalytical and Nuclear Chemistry 304 (2), 633-643 , 2015
    2015
    Citations: 9
  • A systematic study on herbal cream for various clinical and therapeutic application: current status and future prospects
    A Behera, NK Sethiya, S Shilpi
    Journal of Herbal Medicine 45, 100880 , 2024
    2024
    Citations: 6
  • Concentration‐and Solvent‐Induced Chiral Tuning by Manipulating Non‐Proteinogenic Amino Acids in Glycoconjugate Supra‐Scaffolds: Interaction with Protein, and Streptomycin Delivery
    A Ghosh, J Mandal, SK Dubey, S Padma, NN Ghosh, A Behera, SA Hafiz, ...
    Chemistry–A European Journal 29 (70), e202302529 , 2023
    2023
    Citations: 5
  • Pharmacological Potential of Sulindac and Its Active Metabolite: A Comprehensive Review
    SM Gupta, A Behera, S Singh
    Current Drug Therapy 19 (7), 765-779 , 2024
    2024
    Citations: 3
  • Artificial intelligence-based protein structure prediction and systems biology-guided smart drug screening
    A Chandra, N Goyal, A Behera, J Samanta, T Sharma
    Biochemical and Molecular Pharmacology in Drug Discovery, 323-352 , 2024
    2024
    Citations: 3
  • Development, Implementation, And Evaluation of An Informatics Platform for Home Based Self-Management of Chronic Obstructive Pulmonary Disease: A Study Protocol
    A Verma, A Behera, KMM Islam, A Joshi
    National Journal of Community Medicine 14 (07), 446-451 , 2023
    2023
    Citations: 3
  • Radiolabeled novel peptide for imaging somatostatin-receptor expressing tumor: synthesis and radiobiological evaluation
    K De, A Behera, I Banerjee, B Sarkar, S Ganguly, M Misra
    Journal of Radioanalytical and Nuclear Chemistry 301 (3), 847-861 , 2014
    2014
    Citations: 3
  • Metabolic stability and biological evaluation of 99m Tc-HYNIC-Tyr 3 -Octreotide as somatostatin receptor positive tumor imaging agent
    A Behera, K De, S Chattopadhayay, M Misra
    Journal of Radioanalytical and Nuclear Chemistry 304 (2), 595-602 , 2015
    2015
    Citations: 2

Publications

1. Indene-derived hydrazides targeting Acetylcholinesterase enzyme in Alzheimer: Design, Synthesis, and Biological Evaluation. IF6.5 (Q1) Pharmaceutics 2023, 15(1), 94; . Ashok Behera
2. A comprehensive review on Pharmacologically active Phyto-constituents
from Hedychium species Manuscript ID: molecules-2255689, Journal: Molecules Authors: Alok Pratap Singh, Havagiray Chitme, Rajeev Kumar Sharma *, JB
Kandpal, Ashok Behera, Basel A. Abdel-Wahab, Masood Medleri Khateeb, Mohammed
Shafiuddin Habeeb, Mohammed Abdelmalek Orabi, Marwa Mohamed Bakir
Received: 16 February 2023.
3. Computational ADME analysis and Antioxidant potential of 5-methoxy-2-methyl-1H-indol-3-yl)-N'- (substituted benzylidene) acetohydrazide derivatives for . Journal of International academy of Physical Sciences (J. Int. Acad. Phys. Sci.) Vol. 26 No. 4(2022) , 2022. ISSN 0974 -9373. Dec15,2022. (index journal) Shraddha Manish Gupta, Neetesh K Jain, Ashok Behera. .
4. A mini review on Bioequivalence & the Bioavailability study on anticancer drugs, Article ID: BEBA-MRW-23-194, Bioequivalence & Bioavailability International Journal, February 27, 2023.

5. Digital health interventions for the self-management of COPD: Protocol for a Systematic Literature Review: Digital health interventions for the self-management of COPD" to Online Journal of Public Health Informatics[OJPH

RESEARCH OUTPUTS (PATENTS, SOFTWARE, PUBLICATIONS, PRODUCTS)

1. BERBERIN LOADED HYBRID NANOPARTICLE COMPOSITION FOR
TREATMENT OF NEURODEGENERATION” Rhythm Khatri; Dr. Habban Akhter; Dr. Ashok Behera, Dit University, filling date 27/6/2022, application no. 202211036866, published date 8/7/2022.
2. “5-Fluorouracil-1-acetic acid (5-fua) loaded chitosan nanoparticle composition and method for preparation thereof” Ram Prabesh Patel, Jagganath Sahoo, Dr. Ashok Behera, Dit University, filling date 30/6/2022, application no. 202211037593, published date 15/7/2022.
3. “Indomethacin derivatives as multitargeting agent for alzheimer's disease management and process for” Shraddha M Gupta, Dr. Neetesh K Jain, Dr. Ashok Behera, Dr. Devendra Kumar, Dr. Dinesh Rishipathak filling date 30/6/2022, application no. 202211065309, published date 25/11/2022.
4. Develop, implement, and evaluate an informatics platform for home based self- management of Chronic Obstructive Pulmonary Disease, Ashwani Verma, Dr. Ashok Behera, Dr. KM Monirul Islam Feb2023, submitted to cell DITU.